Back to Results
First PageMeta Content



EURL ECVAM progress report on the development, validation and regulatory acceptance of alternative methodsPrepared in the framework of DirectiveEEC and Regulation (EC) No
Add to Reading List

Document Date: 2016-05-27 07:19:55


Open Document

File Size: 490,04 KB

Share Result on Facebook

City

Brussels / /

Company

hCLAT / EURL ECVAM / European Union Reference Laboratory / Ames / Cosmetics Europe / /

Country

United States / Luxembourg / /

Currency

pence / EUR / /

/

Event

Business Partnership / FDA Phase / /

Facility

European Union Reference Laboratory / EN European Commission Joint Research Centre Institute / /

/

IndustryTerm

non-topical pharmaceuticals / cosmetic products / toxicokinetic and toxicodynamic applications / mobile telephone operators / in vitro technologies / chemicals / predictive tool / /

OperatingSystem

Fermi / /

Organization

European Commission Joint Research Centre Institute for Health and Consumer Protection Contact / United Nations / ECVAM Scientific Advisory Committee / Publications Office / European Commission / European Union / European Parliament / Organisation for Economic Cooperation and Development / OECD / Joint Research Centre / /

Person

Camilla Bernasconi / Andrew Worth / Annett Janusch Roi / Silvia Casati / Arch Toxicol / Sharon Munn / Pilar Prieto / Patric Amcoff / Michael Schäffer / Paolo Castello / Susanne Bremer / Anita M. Tuomainen / George Kirmizidis / Sandra Coecke / Maurice Whelan / /

/

Product

EIT / SkinEthic™ HCE / EpiOcular™ EIT / HCE / /

Technology

bioinformatics / EpiOcular™ EIT protocol / in vitro technologies / SkinEthic™ HCE protocols / pdf / /

URL

http /

SocialTag